Thumbs up for Novo Nordisk obesity drug

September 12, 2014 12:58 PM

4 0

Thumbs up for Novo Nordisk obesity drug

The decision is an important step towards its release in the US

The Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the American Food and Drug Administration (FDA) has voted in favour of approving Novo Nordisk’s new product Saxenda, a drug for the treatment of obesity, the company announced in a press release yesterday.

Read more

To category page

Loading...